Abstract
Covid-19 requires policy makers to consider evidence on both population health and economic welfare. Over the last two decades, the field of health economics has developed a range of analytical approaches and contributed to the institutionalisation of processes to employ economic evidence in health policy. We present a discussion outlining how these approaches and processes need to be applied more widely to inform Covid-19 policy; highlighting where they may need to be adapted conceptually and methodologically, and providing examples of work to date. We focus on the evidential and policy needs of low- and middle-income countries; where there is an urgent need for evidence to navigate the policy trade-offs between health and economic well-being posed by the Covid-19 pandemic.
Highlights
Covid-19 (C19) requires a ‘whole society’ policy response to protect health, economic and social welfare globally
We examine here how health economic evidence and more broadly priority setting processes to support decisions around new health technologies and public health policies need to be adapted for C19, focussing on low- and middle-income countries (LMICs)
We call for increased in investment in health economics evidence and evidence informed deliberative policy decisions that consider both health and economic impact
Summary
Publication in Wellcome Open Research does not imply endorsement by Wellcome
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
